Toxicity and efficacy of lenvatinib plus pembrolizumab in advanced endometrial cancer: a real-world retrospective analysis [0.03%]
仑伐替尼联合派姆单抗治疗晚期子宫内膜癌的疗效和毒性：真实世界回顾性分析
Mali Barbi,Chung-Shien Lee,Husneara Rahman et al.
Mali Barbi et al.
Background: The treatment landscape for advanced recurrent endometrial cancer (EC) has been transformed with the introduction of lenvatinib and pembrolizumab, supported by results from the KEYNOTE-775 trial. However, the ...
PEComa progressed by mTOR inhibitor therapy with anti-VEGFR TKI combined with PD-1 inhibitor: a case report [0.03%]
报告一例mTOR抑制剂治疗进展后联合抗VEGFR TKI和PD-1抑制剂获益的PEComa患者
Guannan Wang,Lili Sun,Jian Guan et al.
Guannan Wang et al.
Malignant perivascular epithelioid cell tumors (PEComas) are rare tumors in which the PI3K/AKT/mTOR pathway is critical for pathogenesis and is often associated with mutations in the TSC1/TSC2 genes. First-line mTOR inhibitors are an effect...
Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma [0.03%]
病例报告：苏泰替尼联合特瑞普利单抗治疗1例肺大细胞神经内分泌癌的疗效及机制分析
Shuanglong Xiong,Chengxiang Yang,Kaiwen Fu et al.
Shuanglong Xiong et al.
Background: Large-cell neuroendocrine lung carcinoma (LCNEC) is a rare heterogeneous tumour with rates ranging from 2.1% to 3.5%. The overall prognosis of pulmonary LCNEC is poor, and the 5-year overall survival rate is o...
Posterior reversible encephalopathy syndrome after CD19 chimeric antigen receptor therapy for B-acute lymphoblastic leukemia: case report [0.03%]
CD19嵌合抗原受体疗法治疗B细胞急性淋巴细胞白血病后出现可逆性脑病综合征：病例报告
Rohan Dipesh Agarwal,Ranju Kunwor,Kavya Sudanagunta
Rohan Dipesh Agarwal
Posterior reversible encephalopathy syndrome (PRES) is a neurologic condition characterized by distinctive radiologic findings and altered mental status, often associated with chemotherapy or systemic endothelial dysfunction. To date, there...
Development and validation of machine learning-based MRI radiomics models for preoperative lymph node staging in T3 rectal cancer [0.03%]
基于机器学习的MRI影像组学模型在T3期直肠癌术前淋巴结分期中的应用及验证
Xuelei Qubie,Weijuan Chen,Jun Chen et al.
Xuelei Qubie et al.
Objective: The present research aimed to evaluate the diagnostic performance of a magnetic resonance imaging (MRI)-based radiomics model for predicting lymph node staging in patients with stage T3 rectal cancer (RC). ...
Rectal gastrointestinal stromal tumor with early liver metastasis misdiagnosed as vaginal wall tumor: a rare case report [0.03%]
误诊为阴道壁肿瘤的直肠胃肠间质瘤伴早期肝转移1例报告
Xiuzhang Yu,Zhijiang Fang,Liyan Huang et al.
Xiuzhang Yu et al.
Rectal gastrointestinal stromal tumors (GISTs) are rare mesenchymal tumors of the gastrointestinal tract. They lack specific clinical manifestations and imaging characteristics, leading to a high risk of misdiagnosis and missed diagnosis. H...
Pharmacologic management of HR+/HER2- mBC: a clinically oriented review [0.03%]
HR+/HER2-转移性乳腺癌的药物治疗：以临床为导向的文献回顾
Elena Diana Chiru,Lina Sojak,Julia Landin et al.
Elena Diana Chiru et al.
Breast cancer (BC) remains the most prevalent cancer among women worldwide, with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) subtypes representing approximately 75% of cases. Endocrine thera...
Supporting the global reduction of cervical cancer: challenges in colposcopy practice and training [0.03%]
支持全球降低宫颈癌负担：阴道镜实践与培训的挑战
Takuma Fujii,Yusuke Taira,Grainne Flannelly et al.
Takuma Fujii et al.
Colposcopy is an important element in the global challenge of reducing cervical cancer incidence. However, there are issues with expanding its use globally, including resources, training of colposcopists and quality assurance. This narrativ...
Safety and efficacy of left-sided three-port laparoscopic gastric cancer surgery: a prospective observational study [0.03%]
左半三孔腹腔镜胃癌手术的疗效和安全性：前瞻性观察研究
Xuan Fang,Ziyang Li,Xiaopeng Gao et al.
Xuan Fang et al.
Background: While reduced-port laparoscopic gastrectomy(RPLG) has emerged as a minimally invasive alternative, its standardization and long-term efficacy remain underexplored. This study evaluates the comparative outcomes...
Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs [0.03%]
纠正：TPL通过靶向PI3K/AKT/NF-κB信号通路抑制M2肿瘤相关巨噬细胞的极化来抑制耐药卵巢癌的侵袭和迁移
Fuyin Le,Lilan Yang,Yiwen Han et al.
Fuyin Le et al.
[This corrects the article DOI: 10.3389/fonc.2021.704001.]. Keywords: A2780/DDP cells; PI3K/AKT/NF-κB- path...
Published Erratum
Frontiers in oncology. 2025 Sep 8:15:1641399. DOI:10.3389/fonc.2025.1641399 2025